N,N-Diethyl-1,3-propanediamine → HCID 14800142, compound
Reaction equation
[CH2:1]([N:3]([CH2:6][CH2:7][CH2:8][NH2:9])[CH2:4][CH3:5])[CH3:2].[CH2:10]1[CH2:15][C@@H:14]2[CH2:16][CH2:17][CH2:18][C:19](=O)[C@H:13]2[CH2:12][CH2:11]1>>[CH2:1]([N:3]([CH2:4][CH3:5])[CH2:6][CH2:7][CH2:8][NH:9][CH:15]1[CH:14]2[CH:13]([CH2:19][CH2:18][CH2:17][CH2:16]2)[CH2:12][CH2:11][CH2:10]1)[CH3:2]Participants
3
Procedure
Following the general procedure of Example 46, but starting with diethylaminopropylamine and trans-1-decalone, the title compound is produced. IR (liquid film) 3307, 2968, 2920, 2853, 2799, 1455, 1447, 1383, 1369, 1201, 1164, 1159, 1128, 1105, 1085, 1070. (PLA 2, diabetes-)
Sources & evidence
- ORD record
- ord-fb0c7091eeb14cd9ad2561aa98dba0dd
- Source dataset
- uspto-grants-1990_04
- Patent number
- US04917826
Reaction notes
Loading…